Average Co-Inventor Count = 12.48
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (10 from 4,177 patents)
2. Abbvie Inc. (8 from 822 patents)
18 patents:
1. 9464072 - Treatment of central nervous system disorders
2. 9290444 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
3. 9163007 - 5-substituted indazoles as kinase inhibitors
4. 9133145 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
5. 8993632 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
6. 8940902 - Treatment of central nervous system disorders
7. 8716345 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
8. 8648069 - 5-substituted indazoles as kinase inhibitors
9. 8415354 - Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10. 8314270 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
11. 8198331 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12. 7880001 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
13. 7855308 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
14. 7671076 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
15. 7528282 - Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme